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Abstract Introduction
(Millipore #05-636-AF647) was diluted 1:750; Poly ADP-Ribose Polymer (PAR) (abcam 160 #ab14460) was diluted 1:200; p53 (Life Technologies #MA514516) was diluted 1:200; 161 and PARP1 (Santa Cruz Biotechnology #sc53643 clone C2-10) was diluted 1:200. After 162 primary incubation, cells were washed 3x in PBS and secondary antibodies were diluted 163 1:2000 in 2% BSA and incubated for 45 min at room temperature in the dark. 164 Secondary antibodies were either goat anti-Mouse Alexa Fluor 546 (Invitrogen 165 #A11003), goat anti-Rabbit Alexa Fluor 546 (Invitrogen #A11010), goat anti-Mouse 166 Alexa Fluor 488 (Invitrogen #A11001), or goat anti-Rabbit Alexa Fluor 488 (Invitrogen 167 #A11008). One drop of NucBlue™ Fixed Cell Reagent (ThermoFisher #R37606) was 168 added to each chamber and chambers were incubated for 15 min at room temperature. 169 Cells were washed 2x in PBS and imaged immediately for analysis or stored at 4°C 170 overnight. Fluorescence images were acquired using a Nikon A1r scanning confocal 171 microscope with a Plan-Apochromat 20x/0.75 objective. For quantification, the region of 172 interest (ROI) generator was used to automatically detect nuclei in the DAPI channel, 173 and the mean intensity in the channel of interest was exported for analysis. For XRCC1 174 and POL β nucleus to cytoplasmic ratio (N/C), nuclei were defined automatically and the 175 whole cell was drawn using Bezier function. The nucleus was then subtracted from the 176 whole cell intensity to determine cytoplasmic intensity described previously [26, 27] . 177 355 nm Laser microirradiation 178 Cells were plated as for immunofluorescence in 8-well chambered coverglass at 179 4 x 10 4 cells per chamber. The next day, cells were treated with 10 µM 180 bromodeoxyuridine BrdU (Sigma Aldrich #B5002) for 24 hours to sensitize the cells to 181 microirradiation. Microirradiation was performed on a Nikon A1r scanning confocal microscope that was modified to include a 355 nm laser. Experiments were performed 183 using an ultraviolet passing S Fluor 20x/0.75 objective as described previously [28, 29] . 184 Samples were fixed with 3.7% formaldehyde at various time points and processed by 185 immunofluorescence for XRCC1 fluorescence intensity. Intensity levels of damage foci 186 were normalized by subtracting an adjacent region within the nucleus and reported as 187 fluorescence intensity in arbitrary units (a.u.) as described [28] . blocked using 2% BSA in PBS and Dig was then detected using an anti-Dig antibody 204 (abcam #ab420 clone 21H8) at a dilution of 1:250 in 2% BSA in PBS for 1 hour at room 205 temperature. Samples were then counterstained with Alexa Fluor goat anti-mouse 546 206 at 1:400 in 2% BSA in PBS for 45 min at room temperature and nuclei were stained as 207 for immunofluorescence. Image analysis was performed as described previously [30] .
208
MDA-231 cells were used to set the 546 nm laser gain, and the other cells were imaged 209 at that gain. The control experiment was performed with the complete RADD cocktail were significantly higher in primary tumor samples than in normal tissues with a p value 232 of 1.6 x 10 -12 ( Fig 1A) . Further analysis of XRCC1 expression across breast cancer 233 types shows increased expression of XRCC1 in Luminal (p < 1 x 10 -12 ) and TNBC (p < 234 0.001) tumor types ( Fig 1B) , but not in HER2 positive tumors. 
Subcellular localization of critical base excision repair proteins 262
For effective DNA repair and maintenance of genomic fidelity, the proteins 263 involved must be localized in the nucleus. We examined the expression and nuclear 264 localization of XRCC1 and POL β using immunofluorescence. Previous studies showed 265 that POL β stability may depend on interactions with XRCC1 [41-43], and XRCC1 266 localization has been previously observed to be primarily nuclear [26] . POL β functions 267 in both nuclear and mitochondrial BER and is observed within the cytoplasm, 268 mitochondria, and nucleus of cells [27, 44] . 269 We assessed the nuclear to cytoplasmic ratio (N/C) of XRCC1, with a value of 1 270 representing equal distribution between the nucleus and cytoplasm, while a value of 271 less than one represents exclusion from the nucleus, and a value greater than one 272 represents predominantly nuclear localization. The MDA-157 cells exhibited relatively 273 equal distribution of XRCC1 between the nucleus and cytoplasm with a N/C ratio of 1.01 274 ± 0.03 ( Fig 3A and 3C ). MDA-231 showed higher nuclear content of XRCC1 with a N/C 275 ratio of 2.02 ± 0.12, though some cytoplasmic content is still observed. HCC1806 cells 276 had partial exclusion of XRCC1 from the nucleus with a N/C ratio of 0.79 ± 0.02 ( Fig 3A   277 and 3C). MDA-468 cells had the highest N/C ratio of the cell lines tested (2.36 ± 0.12) 278 with XRCC1 almost exclusively in the nucleus ( Fig 3A and 3C) . 0.02 and 0.45 ± 0.02, respectively ( Fig 3B) , in contrast to the nuclear content of XRCC1 291 in these cell lines. HCC1806 showed nuclear enrichment of POL β with an N/C of 1.40 ± 292 0.37, despite XRCC1 being predominately cytoplasmic ( Fig 3B and 3D) . MDA-468 cells 293 also had enriched nuclear POL β with an N/C of 1.24 ± 0.08.
294
Given the unexpected distribution of BER factors, we also examined cellular 295 levels of PAR, which is polymerized by PARP1 at sites of DNA damage, and increases 296 in the presence of BER defects [42, 45] . Nuclear levels of PAR were varied, with MDA-297 157 cells having the highest nuclear intensity of PAR and HCC1806 cells unexpectedly 298 having the lowest nuclear intensity of PAR, despite XRCC1 being largely cytoplasmic 299 ( Fig 4A) . 
304
We then examined the nuclear content of PARP1 and p53. MDA-157 contained 305 roughly 2.4-fold more nuclear PARP1 than MDA-231 cells. HCC1806 had 1.6-fold and 306 MDA-468 1.9-fold more nuclear PARP1 than MDA-231 cells ( Fig 4A) . PARP1 was 307 highly localized to the nucleus in all cell lines ( Fig 4B) . We observed that p53 nuclear 
334
XRCC1 recruitment to single-strand breaks is altered in TNBC cells 335 The varied levels of basal DNA damage and altered expression and localization 336 of XRCC1 indicated that DNA repair functions of XRCC1 may be altered in TNBC cells.
337
As XRCC1 has no known enzymatic activity, we assessed DNA repair activity by 338 examining the recruitment and retention of XRCC1 at sites of DNA damage induced by 339 laser microirradiation. Single-strand breaks were induced in a subnuclear region by 340 microirradiation with a 355 nm laser, and we assessed XRCC1 recruitment and 341 retention to the damage sites at various time points after inducing damage [28, 29] .
342
As shown in Fig 6, XRCC1 recruitment over time is graphed on the left, with 343 corresponding images of peak XRCC1 recruitment foci shown on the right. XRCC1 was 344 recruited to the DNA damage spot in MDA-157 cells with an average intensity of 707 345 a.u. that was resolved within 5 minutes, with 50% retention at 1.7 minutes ( Fig 6A) . In 346 contrast, MDA-231 cells had two peaks of XRCC1 recruitment at 364 a.u. within 0.5 347 minutes that resolved by 3 min, and at 8 minutes ( Fig 6B) . XRCC1 in HCC1806 cells 348 had weak recruitment to the damage spot, peaking only at 258 a.u., likely due to 349 mislocalization of XRCC1 as indicated in Fig 3A (Fig 6C) . In MDA-468 cells, XRCC1 350 recruitment was rapid and robust, peaking at 1025 a.u. within 0.5 minutes and 50% 351 retention at 2.2 minutes ( Fig 6D) , and XRCC1 was rapidly dissociated from the damage 352 site, with complete resolution of the damage foci within 3 minutes of microirradiation 353 ( Fig 6D) . Double-strand breaks (DSBs) were absent in all cell lines as confirmed by the 354 lack of co-localization of DSB markers 53BP1 and γH2AX at 10 minutes after 355 microirradiation, except for a slight increase of γH2AX at 10 minutes in HCC1806 cells 356 (S4 Fig, and S5 Fig) . GFP_hypoxanthine:T, which primarily reports AAG (also known as MPG) glycosylase-374 mediated excision of hypoxanthine opposite thymine ( Fig 7A) ; mPlum_A:8-oxo-dG, 375 which reports MUTYH glycosylase catalyzed excision of adenine opposite 8-oxo-2'-376 deoxyguanosine (8-oxo-dG) ( Fig 7B) ; mOrange_8-oxo-dG:C, which reports the activity 377 of several glycosylases (OGG1, NEIL1, NEIL2) that excise 8-oxo-dG opposite cytosine 378 ( Fig 7C) ; and BFP_Uracil:G, which primarily reports UNG glycosylase catalyzed 379 excision of uracil opposite guanine ( Fig 7D) . mPlum_O 6 -methylguanine:C was used to 380 assess removal of O 6 -methylguanine opposite thymine by MGMT ( Fig 7E) . 397 We then analyzed sensitivity of the four TNBC cell lines to clinical DNA damaging 398 agents. Toxic effects of cisplatin and doxorubicin have been widely reported for these 399 cell lines with a large range of IC50 values observed (Table 1) XRCC1 was almost exclusively located in the nucleus (Fig 3A and 3C) MDA-157 cells to MMS and other DNA damaging agents (Fig 7, Table 1 ).
396

DNA damaging agents induce selective cytotoxicity in TNBC cells
481
The consequences of DNA repair defects in TNBC cells were observed with a 482 broad spectrum method of detecting DNA damage [30] . Levels of XRCC1 (Fig 2) Elevated levels of BER in MDA-468 cells are consistent with the proficiency of 494 these cells to repair BER substrates (Fig 7) by the rapid and robust recruitment of 495 XRCC1 to laser induced DNA damage (Fig 6) , and the resistance of these cells to MMS 496 ( from the low nuclear content of these cells (Fig 6) [42], or could possibly be due to a 504 more complex BER pathway that is needed for correct end-tailoring of nicked DNA 505 before gap-filling by the polymerase [28] . Further work is needed to better understand 506 these recruitment dynamics.
507
The inefficiency in BER repair by MDA-231 cells was confirmed by the FM-HCR 508 assays (Fig 7) and high sensitivity of MDA-231 cells to MMS (Table 1 ). The MDA-231 509 cells were not sensitive to olaparib alone and the least sensitive to KBrO3 of the lines 510 tested, despite the defect in BER (Table 1) . The sensitivity to olaparib may be reduced 511 due to the lower levels of its target PARP1 observed in MDA-231 cells (Fig 2) , while the 512 lack of sensitivity to KBrO3 is likely due to the fact that while the MDA-231 cells are the 513 least efficient in BER XRCC1 is still able to recruit to sites of damage ( Fig 6) . As the 514 levels of DNA damage observed in this cell line are more comparable to BER 515 competent MDA-157, low levels of PARP1 and the gain-of-function mutation in p53 516 observed in MDA-231 cells likely promote alternative repair pathways to reduce basal 517 damage levels ( Fig 5) [33]. Competition or ineffective signaling by these alternative 518 repair pathways also may explain the altered recruitment profile for XRCC1 in the MDA-519 231 cells.
520
Although MDA-468 and MDA-231 cells represented the extremes of BER 521 competencies, the observed sensitivity of MDA-157 and HCC1806 cells to MMS likely 522 resulted from the observed defects in localization of BER proteins, which has not been 523 previously assessed (Fig 3) .
524
Characterization of XRCC1 expression in these preclinical models demonstrates these cells may generate too many cytotoxic intermediates that promote cell death and 530 increase cellular sensitivity to DNA damaging agents, such as KBrO3 (Table 1) , 531 rendering these cells ineffective model for drug evaluation. The present data also 532 demonstrate that defects in BER are prominent in the commonly used TNBC preclinical 533 models. These BER defects have not been characterized or examined previously and 534 need to be investigated in patient tumor samples.
535
In summary, XRCC1 expression and localization may vary and serve as critical 
